Call Now

Recombinant Protein to Rattus norvegicus (Rat) Von Hippel Lindau Tumor Suppressor (vHL)

HRCA1; RCA1; VHL1; Von Hippel-Lindau Syndrome

DescriptionVon Hippel Lindau Tumor Suppressor (vHL)
Description Von Hippel Lindau Tumor Suppressor (vHL)
Catalog NumberN996Ra01
Organism SpeciesRattus norvegicus (Rat)
SourceProkaryotic expression
Expression SystemE. coli
Endotoxin Level <1.0 EU per 1 µg (determined by the LAL method)
Subcellular Localizationn/a
Predicted Molecular Mass23.3kDa
Accurate Molecular Massn/a
Residues & TagsAla6~Gln175 with N-terminal His Tag
Buffer Formulation 20 mM Tris, 150 mM NaCl, pH 8.0, 5% Trehalose and Proclin 300.
Form Supplied Lyophilized powder
Purity Purity was assessed by SDS-PAGE (≥98%) and by HPLC.
SDS-PAGE SDS-PAGE image for Von Hippel Lindau Tumor Suppressor (vHL)
Isoelectric Pointn/a
Applications Positive Control; Immunogen; SDS-PAGE; WB.
Storage Instruction We recommend a quick spin followed by reconstitution in water to a concentration of 0.1–1.0 mg/mL. This solution can then be diluted into other aqueous buffers and stored at 4°C for 1 week or at -20°C for future use.
Stability The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation testing at 37°C for 48 hours. No obvious degradation or precipitation was observed under the stated test conditions. The loss rate is less than 5% within the expiration date under appropriate storage conditions.
Notes For in vitro laboratory use only. Not for clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.